News|Articles|April 2, 2004
- Pharmaceutical Technology-04-02-2004
- Volume 28
- Issue 4
Spotlight on Business Risk
Author(s)Jim Miller
Recent events in the pharmaceutical outsourcing industry highlight the importance of ongoing attention to contractors' financial situations and their strategic intent.
Advertisement
Articles in this issue
over 22 years ago
Vibration Technology for Active Dry-Powder Inhalersover 22 years ago
In the Spotlight April 2004over 22 years ago
FDA Attacks Counterfeitsover 22 years ago
Synthetic Excipients Challenge All-Natural Organicsover 22 years ago
April 2004over 22 years ago
Controlled-Release Dosage Forms for Diltiazem HydrochlorideAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
2
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
3
Everything to Know about BMS & NVidia’s AI Supercomputer
4
PharmTech Weekly Roundup—July 17, 2026
5